How a Modified Nucleoside Boosts Protein Production in mRNA

Updated

Abstract

The success of mRNA vaccines against COVID-19 highlights the promise of synthetic mRNA in medicine. A key ingredient in these vaccines is a modified nucleoside called N1-methylpseudouridine, which helps produce more proteins while reducing unwanted immune responses. This study examines how this modification affects the process of translating mRNA into proteins. We found that N1-methylpseudouridine increases the presence of ribosomes on mRNAs, leading to higher protein levels. It slows down the movement of ribosomes while also helping to start the translation process. Our structural studies show that this modification changes how ribosomes interact with mRNA, providing insights into how it enhances protein production, especially in mRNAs with specific sequences. Overall, our findings reveal that N1-methylpseudouridine plays a crucial role in improving protein yield from synthetic mRNAs.

Simplified

Funding

Competing interests

Competing interests: The authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free